{"id":"https://openalex.org/W2076596273","doi":"https://doi.org/10.1080/000155502320323216","title":"Bacterial Resistance and Therapeutic Outcome Following Three Months of Topical Acne Therapy with 2% Erythromycin Gel Versus Its Vehicle","display_name":"Bacterial Resistance and Therapeutic Outcome Following Three Months of Topical Acne Therapy with 2% Erythromycin Gel Versus Its Vehicle","alternate_titles":[],"publication_year":2002,"publication_date":"2002-07-01","ids":{"openalex":"https://openalex.org/W2076596273","doi":"https://doi.org/10.1080/000155502320323216","mag":"2076596273","pmid":"https://pubmed.ncbi.nlm.nih.gov/12361129"},"language":"en","primary_location":{"id":"doi:10.1080/000155502320323216","doi":"https://doi.org/10.1080/000155502320323216","is_oa":true,"landing_page_url":"https://doi.org/10.1080/000155502320323216","pdf_url":null,"source":{"id":"https://openalex.org/S4210210846","display_name":"Acta Dermato Venereologica","issn_l":"0001-5555","issn":["0001-5555","1651-2057"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317100","host_organization_name":"Soc for Publication of\u00a0Acta Dermato-Venereologica","host_organization_lineage":["https://openalex.org/P4310317100"],"host_organization_lineage_names":["Soc for Publication of\u00a0Acta Dermato-Venereologica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Dermato-Venereologica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2076596273"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1080/000155502320323216","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111744218","display_name":"Otto H. Mills","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160190","display_name":"Hill Top Research (United States)","ror":"https://ror.org/054r3wx31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160190"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Otto Mills Jr","raw_affiliation_strings":["Hill Top Research, East Brunswick, New Jersey, USA. ohmills@aol.com","Hill Top Research, East Brunswick, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hill Top Research, East Brunswick, New Jersey, USA. ohmills@aol.com","institution_ids":["https://openalex.org/I4210160190"]},{"raw_affiliation_string":"Hill Top Research, East Brunswick, New Jersey, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059192444","display_name":"Clyde Thornsberry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clyde Thornsberry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012903322","display_name":"Caroline W. Cardin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline W. Cardin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040300510","display_name":"Kenneth A. Smiles","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth A. Smiles","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"James J. Leyden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Leyden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1600,"currency":"EUR","value_usd":1725},"apc_paid":{"value":1600,"currency":"EUR","value_usd":1725},"fwci":2.6273,"has_fulltext":false,"cited_by_count":121,"citation_normalized_percentile":{"value":0.87958061,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"82","issue":"4","first_page":"260","last_page":"265"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.972000002861023},{"id":"https://openalex.org/keywords/erythromycin","display_name":"erythromycin","score":0.8309999704360962},{"id":"https://openalex.org/keywords/topical-antibiotics","display_name":"topical antibiotics","score":0.8600000143051147},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.7940000295639038},{"id":"https://openalex.org/keywords/coagulase-negative-staphylococci","display_name":"coagulase-negative staphylococci","score":0.9229999780654907},{"id":"https://openalex.org/keywords/macrolide-resistance","display_name":"macrolide resistance","score":0.9589999914169312},{"id":"https://openalex.org/keywords/bacterial-density","display_name":"bacterial density","score":0.3490000069141388},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C2780206985","wikidata":"https://www.wikidata.org/wiki/Q213511","display_name":"Erythromycin","level":3,"score":0.9364485740661621},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.8856886625289917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8676155805587769},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.6285739541053772},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5307742357254028},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.5247581005096436},{"id":"https://openalex.org/C2777458120","wikidata":"https://www.wikidata.org/wiki/Q422273","display_name":"Clindamycin","level":3,"score":0.4735371768474579},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.47090959548950195},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38956061005592346},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.2693396806716919},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.253581166267395},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07585042715072632}],"mesh":[{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004917","descriptor_name":"Erythromycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004917","descriptor_name":"Erythromycin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005782","descriptor_name":"Gels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D013210","descriptor_name":"Staphylococcus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024881","descriptor_name":"Drug Resistance, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/000155502320323216","doi":"https://doi.org/10.1080/000155502320323216","is_oa":true,"landing_page_url":"https://doi.org/10.1080/000155502320323216","pdf_url":null,"source":{"id":"https://openalex.org/S4210210846","display_name":"Acta Dermato Venereologica","issn_l":"0001-5555","issn":["0001-5555","1651-2057"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317100","host_organization_name":"Soc for Publication of\u00a0Acta Dermato-Venereologica","host_organization_lineage":["https://openalex.org/P4310317100"],"host_organization_lineage_names":["Soc for Publication of\u00a0Acta Dermato-Venereologica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Dermato-Venereologica","raw_type":"journal-article"},{"id":"pmid:12361129","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12361129","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta dermato-venereologica","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1080/000155502320323216","doi":"https://doi.org/10.1080/000155502320323216","is_oa":true,"landing_page_url":"https://doi.org/10.1080/000155502320323216","pdf_url":null,"source":{"id":"https://openalex.org/S4210210846","display_name":"Acta Dermato Venereologica","issn_l":"0001-5555","issn":["0001-5555","1651-2057"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317100","host_organization_name":"Soc for Publication of\u00a0Acta Dermato-Venereologica","host_organization_lineage":["https://openalex.org/P4310317100"],"host_organization_lineage_names":["Soc for Publication of\u00a0Acta Dermato-Venereologica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Dermato-Venereologica","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1980595924","https://openalex.org/W2024182874","https://openalex.org/W2056883846","https://openalex.org/W2078785671","https://openalex.org/W2162481463"],"related_works":["https://openalex.org/W4323646422","https://openalex.org/W205384284","https://openalex.org/W2150806352","https://openalex.org/W2075642873","https://openalex.org/W2080487006","https://openalex.org/W2029777010","https://openalex.org/W2787536014","https://openalex.org/W2131797856","https://openalex.org/W2403457669","https://openalex.org/W2010648837"],"abstract_inverted_index":{"Two-hundred-and-eight":[0],"acne":[1],"vulgaris":[2],"patients":[3],"were":[4,56,132,149],"enrolled":[5],"in":[6,100,140],"a":[7,21,29,45],"24-week":[8],"study":[9],"to":[10,95,162],"determine":[11],"the":[12,18,37,59,86,101,136,141,146,163],"bacterial":[13],"resistance":[14,70],"issues":[15],"associated":[16],"with":[17,50,119,122],"use":[19],"of":[20,28,81,112,145,166],"topical":[22],"2%":[23],"erythromycin":[24,120],"gel.":[25],"It":[26],"consisted":[27],"12-week":[30,46],"randomized,":[31],"double-blind,":[32],"parallel-group":[33],"treatment":[34,121],"phase":[35,49],"comparing":[36],"active":[38],"gel":[39,51],"versus":[40],"its":[41],"vehicle":[42,52],"followed":[43],"by":[44,66,97],"single-blind":[47],"regression":[48],"only.":[53],"Bacteriological":[54],"samples":[55],"taken":[57],"from":[58],"face,":[60],"back":[61,138],"and":[62,68,104,129,139],"nares":[63],"for":[64],"quantification":[65],"species":[67],"antibiotic":[69],"characteristics.":[71],"Acne":[72],"efficacy":[73,170],"was":[74,88,160,171],"assessed":[75],"through":[76],"week":[77,98],"12.":[78],"The":[79,110],"prevalence":[80,128],"erythromycin-resistant":[82],"coagulase-negative":[83],"Staphylococci":[84],"on":[85,135],"face":[87],"extremely":[89],"high":[90],"(87%)":[91],"at":[92],"baseline,":[93],"increased":[94,118],"98%":[96],"12":[99],"erythromycin-treated":[102],"group":[103],"did":[105],"not":[106],"change":[107,124],"during":[108,125],"regression.":[109,126],"density":[111,130],"these":[113],"resistant":[114,147,151],"organisms":[115],"also":[116,133],"significantly":[117],"no":[123],"Similar":[127],"patterns":[131],"observed":[134],"untreated":[137],"nares.":[142],"Nearly":[143],"all":[144],"isolates":[148],"highly":[150],"(minimal":[152],"inhibitory":[153],"concentrations":[154],">":[155],"128":[156],"microg/ml).":[157],"Resistance":[158],"development":[159],"confined":[161],"macrolide":[164],"class":[165],"antibiotics.":[167],"No":[168],"anti-acne":[169],"observed.":[172]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2076596273","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
